Summary:

- The study found that the plant compound phytoene can extend lifespan and improve cognitive function in animal models of Alzheimer's disease. Phytoene is a precursor to carotenoids, which are known for their antioxidant and anti-inflammatory properties.

- Researchers discovered that phytoene treatment reduced the accumulation of amyloid-beta and tau proteins, which are hallmarks of Alzheimer's disease. This led to improved synaptic function and better cognitive performance in the animal models.

- The findings suggest that phytoene could potentially be a promising therapeutic target for Alzheimer's disease and other age-related neurodegenerative disorders. Further research is needed to explore the mechanisms behind phytoene's neuroprotective effects and to assess its potential for human clinical trials.